Variant-Level Curation and Molecular Context of Therapeutically Relevant Alterations in Parathyroid Carcinoma: A Nationwide C-CAT Analysis in Japan

Abstract Introduction: Parathyroid carcinoma (PC) is an ultra-rare malignancy with limited treatment options. Although comprehensive genomic profiling (CGP) has identified recurrent genomic alterations in PC, the pathogenicity and therapeutic relevance of individual variants and their distribution across molecular subgroups remain incompletely characterized. We aimed to characterize the genomic landscape of PC through variant-level pathogenicity curation and molecular subgroup analysis, with a focus on potentially therapeutically relevant alterations. Methods: We conducted a descriptive analysis of patients with pathologically confirmed PC registered in C-CAT, a Japanese nationwide cancer genomics database. Genomic alterations were systematically curated for pathogenicity using OncoKB and manual review of published and functional evidence. Molecular subgroup analyses were performed in patients with evaluable CDC73 status, classified as CDC73-altered, MEN1-altered, or other tumors. Results: Thirty patients were included. Among 373 unique genomic alterations detected, 114 (30.6%) were classified as pathogenic after variant-level curation. CDC73 (43.3%), TP53 (26.7%), and MEN1 (23.3%) were the most frequently altered genes. High tumor mutational burden (≥ 10 mutations/Mb), mismatch repair (MMR), PI3K–AKT–mTOR, and homologous recombination repair (HRR)-related alterations were identified in 23.3%, 16.7%, 23.3%, and 13.3% of patients, respectively. Only 5 of 25 unique HRR-related alterations (20.0%) were retained as pathogenic after curation. Among 29 patients evaluable for molecular subgroup analysis, therapeutically relevant alterations showed distinct distributions across CDC73-altered, MEN1-altered, and other tumors. CDC73 alterations were mutually exclusive with MEN1, TP53, and PI3K–AKT–mTOR pathway alterations, whereas TP53 alterations co-occurred with PI3K–AKT–mTOR pathway alterations. Conclusions: Variant-level pathogenicity curation substantially refined the genomic alterations identified by CGP in PC, particularly among HRR-related genes. Molecular stratification based on CDC73 and MEN1 revealed distinct patterns of therapeutically relevant alterations, highlighting the importance of interpreting CGP findings within disease-specific molecular contexts.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-10646400/v1
Primary Topic
Parathyroid Disorders and Treatments
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Variant-Level Curation and Molecular Context of Therapeutically Relevant Alterations in Parathyroid Carcinoma: A Nationwide C-CAT Analysis in Japan

Yasuyoshi Sato, Juro Yanagida, Yuji Miura, Naoki Fukuda et al.
Research Square
Parathyroid Disorders and Treatments
preprint

Variant-Level Curation and Molecular Context of Therapeutically Relevant Alterations in Parathyroid Carcinoma: A Nationwide C-CAT Analysis in Japan

Yasuyoshi Sato, Juro Yanagida, Yuji Miura, Naoki Fukuda, Kousuke Watanabe, Jumpei Yoshida, Fujishiro Mitsuhiro, Katsutoshi Oda, Shunji Takahashi
preprint en

Abstract

Abstract Introduction: Parathyroid carcinoma (PC) is an ultra-rare malignancy with limited treatment options. Although comprehensive genomic profiling (CGP) has identified recurrent genomic alterations in PC, the pathogenicity and therapeutic relevance of individual variants and their distribution across molecular subgroups remain incompletely characterized. We aimed to characterize the genomic landscape of PC through variant-level pathogenicity curation and molecular subgroup analysis, with a focus on potentially therapeutically relevant alterations. Methods: We conducted a descriptive analysis of patients with pathologically confirmed PC registered in C-CAT, a Japanese nationwide cancer genomics database. Genomic alterations were systematically curated for pathogenicity using OncoKB and manual review of published and functional evidence. Molecular subgroup analyses were performed in patients with evaluable CDC73 status, classified as CDC73-altered, MEN1-altered, or other tumors. Results: Thirty patients were included. Among 373 unique genomic alterations detected, 114 (30.6%) were classified as pathogenic after variant-level curation. CDC73 (43.3%), TP53 (26.7%), and MEN1 (23.3%) were the most frequently altered genes. High tumor mutational burden (≥ 10 mutations/Mb), mismatch repair (MMR), PI3K–AKT–mTOR, and homologous recombination repair (HRR)-related alterations were identified in 23.3%, 16.7%, 23.3%, and 13.3% of patients, respectively. Only 5 of 25 unique HRR-related alterations (20.0%) were retained as pathogenic after curation. Among 29 patients evaluable for molecular subgroup analysis, therapeutically relevant alterations showed distinct distributions across CDC73-altered, MEN1-altered, and other tumors. CDC73 alterations were mutually exclusive with MEN1, TP53, and PI3K–AKT–mTOR pathway alterations, whereas TP53 alterations co-occurred with PI3K–AKT–mTOR pathway alterations. Conclusions: Variant-level pathogenicity curation substantially refined the genomic alterations identified by CGP in PC, particularly among HRR-related genes. Molecular stratification based on CDC73 and MEN1 revealed distinct patterns of therapeutically relevant alterations, highlighting the importance of interpreting CGP findings within disease-specific molecular contexts.

Research Square
Japanese Foundation For Cancer Research (JP), The University of Tokyo (JP)
Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Sanofi, Taiho Pharmaceutical, Eisai, Astellas Pharma, Ono Pharmaceutical, Chugai Pharmaceutical, Daiichi Sankyo Europe
Good health and well-being
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon